US OptionsDetailed Quotes
ABBV250509P215000
- 36.74
- 0.000.00%
15min DelayTrading Apr 14 15:44 ET
0.00High0.00Low
0.00Open36.74Pre Close0 Volume0 Open Interest215.00Strike Price0.00Turnover0.00%IV8.93%PremiumMay 9, 2025Expiry Date19.25Intrinsic Value100Multiplier4DDays to Expiry17.49Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma10.18Leverage Ratio--Theta--Rho--Eff Leverage--Vega
AbbVie Stock Discussion
Sign in to post a comment
Earnings Preview
Earnings season will intensify in the coming week, with reports expected from over 120 S&P 500 companies, including the Magnificent Seven's $Alphabet-A (GOOGL.US)$ $Alphabet-C (GOOG.US)$ and $Tesla (TSLA.US)$.
Elon Musk's electric vehicle company Tesla, which reports results on Tuesday after the close, is in the spotlight partly due to the billionaire's close ties to Trump. Alphabet is set to report...
Earnings season will intensify in the coming week, with reports expected from over 120 S&P 500 companies, including the Magnificent Seven's $Alphabet-A (GOOGL.US)$ $Alphabet-C (GOOG.US)$ and $Tesla (TSLA.US)$.
Elon Musk's electric vehicle company Tesla, which reports results on Tuesday after the close, is in the spotlight partly due to the billionaire's close ties to Trump. Alphabet is set to report...
+3
65
2
23
$AbbVie (ABBV.US)$
This company's major earnings and factories are all within US. This should be more solid than those like MRK or JNJ if Trump does do the drug tariffs
This company's major earnings and factories are all within US. This should be more solid than those like MRK or JNJ if Trump does do the drug tariffs
2
1
Morning Movers
Gapping Up
$Peabody Energy (BTU.US)$ shares extended gains to 11.10% in pre-market trading after a 9.2% rise yesterday, following President Trump's executive orders aimed at reviving the U.S. coal industry. Trump plans to use the Defense Production Act to support coal mining and next-generation technologies, and instruct the DOJ to challenge regulations affecting coal jobs, aiming to enhance U.S. AI leadership by b...
Gapping Up
$Peabody Energy (BTU.US)$ shares extended gains to 11.10% in pre-market trading after a 9.2% rise yesterday, following President Trump's executive orders aimed at reviving the U.S. coal industry. Trump plans to use the Defense Production Act to support coal mining and next-generation technologies, and instruct the DOJ to challenge regulations affecting coal jobs, aiming to enhance U.S. AI leadership by b...
18
2
2
$AbbVie (ABBV.US)$
What are the key efficacy results of RINVOQ (ABBV) in treating giant cell arteritis?
RINVOQ showed 46.4% sustained remission rate at week 52 vs 29.0% for placebo, with 34.3% disease flare rate vs 55.6% for placebo, and 37.1% sustained complete remission vs 16.1% for placebo.
How does RINVOQ reduce steroid dependency in GCA patients?
RINVOQ demonstrated...
What are the key efficacy results of RINVOQ (ABBV) in treating giant cell arteritis?
RINVOQ showed 46.4% sustained remission rate at week 52 vs 29.0% for placebo, with 34.3% disease flare rate vs 55.6% for placebo, and 37.1% sustained complete remission vs 16.1% for placebo.
How does RINVOQ reduce steroid dependency in GCA patients?
RINVOQ demonstrated...
2
Columns The Whole World Is Waiting for Trump to Wield the Tariff Stick. Here's What You Need to Know
President Donald Trump is gearing up to unveil a significant new set of import tariffs, which he refers to as “Liberation Day,”scheduled to commence this Wednesday (or Tuesday evening). The forthcoming announcement is poised to significantly intensify Trump's ongoing trade conflicts globally, with detailed information expected to be disclosed shortly.
On Monday, Trump suggested that he would be “very kind...
On Monday, Trump suggested that he would be “very kind...
+1
74
24
69
. Good TRUMP!!$AbbVie (ABBV.US)$
AbbVie Unveils Breakthrough Cancer Pipeline: New Dual-Target Drug Shows Promise Against Resistant Tumors
AbbVie Unveils Breakthrough Cancer Pipeline: New Dual-Target Drug Shows Promise Against Resistant Tumors
$AbbVie (ABBV.US)$ ay yi yi, thought there was good stuff in the pipeline. Gonna hold on, historically it is resilient
$ABBV 250328 207.50C$ in at .95 quick flip
$AbbVie (ABBV.US)$ Time to short
p/e at 90, flat revenue since 2021, cash from operation trending down since 2023. dividend payout ratio of 263%. Management is cashing out!
Weekly chart at upper trend channel.
Dont take too long, son. Papa is waiting you at the bottom!
p/e at 90, flat revenue since 2021, cash from operation trending down since 2023. dividend payout ratio of 263%. Management is cashing out!
Weekly chart at upper trend channel.
Dont take too long, son. Papa is waiting you at the bottom!
1
$AbbVie (ABBV.US)$
Breakthrough: ELAHERE Ovarian Cancer Drug Cuts Death Risk by 32%, Doubles Response Rate
Breakthrough: ELAHERE Ovarian Cancer Drug Cuts Death Risk by 32%, Doubles Response Rate
No comment yet
MOHD NOR B ABDULLAH : ok
74128907 :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")